Optos (OPTS) Share Price, News & Analysis

Company Overview

Optos plc is a medical technology company, which is engaged in the design, development, manufacturing and marketing of ultra-wide field (UWF) retinal imaging devices. The Company provides devices to eye care professionals. Its products, Daytona and California, represents its UWF retinal imaging technology, and have been converted to desktop models. Its devices include image modalities, such as color, red-free and auto fluorescence (AF). In addition, the Daytona plus device comes with the OptosAdvance browser-based image review software, which allows for documentation, monitoring and referral processing to assist in patient management. California features fluorescein angiography (FA) and UWF imaging modality, indocyanine green angiography. The Company's devices produce UWF digital images (optomap) of approximately 82% or 200 degree of the retina. Its imaging devices for disease management and treatment support ophthalmologists and retinal specialists in the medical care market.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 747,598 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OPTS Stock Analysis - Frequently Asked Questions

How do I buy shares of Optos?

Shares of OPTS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Manufacturing
• Industry: Electronic Computer Manufacturing
• Sub-Industry: N/A
• Current Symbol: LON:OPTS
• CIK: N/A
• Web: www.optos.com
• Phone: +44-1383-843300
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A